2026-10-08T20:43:04Z https://api.figshare.com/v2/oai

oai:figshare.com:article/34032711 2026-09-30T14:17:01Z category_27232 item_type_3 month_year_09_2026

ARRIVE 2.0 checklist for - <b>Kanglaite injection</b> <b>against non-small cell lung cancer</b> -C57BL/6J LLC cisplatin/KLT study Cuihong Ge (25144263) zhiming xiang (23655232) Traditional Chinese medicine and treatments ARRIVE animal research C57BL/6J LLC model <p dir="ltr">Completed ARRIVE 2.0 checklist (Essential 10 plus Recommended Set) for the in vivo study using immunocompetent wild-type C57BL/6J male mice (6-8 weeks). This checklist documents animal provenance, health/immune status, experimental procedures (LLC tumor inoculation, cisplatin and KLT administration), randomization, blinding, sample size justification, humane endpoints, and statistical methods.</p> 2026-09-30T14:17:01Z Dataset Dataset 10.6084/m9.figshare.34032711.v1 https://figshare.com/articles/dataset/ARRIVE_2_0_checklist_for_-_b_Kanglaite_injection_b_b_against_non-small_cell_lung_cancer_b_-C57BL_6J_LLC_cisplatin_KLT_study/34032711 CC BY 4.0